TORENSA Trademark

Trademark Overview


On Friday, October 28, 2016, a trademark application was filed for TORENSA with the United States Patent and Trademark Office. The USPTO has given the TORENSA trademark a serial number of 87219063. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 4, 2019. This trademark is owned by Novartis AG. The TORENSA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preve...
torensa

General Information


Serial Number87219063
Word MarkTORENSA
Filing DateFriday, October 28, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 4, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 31, 2017

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 2, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, November 4, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 4, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 22, 2019EXTENSION 4 GRANTED
Friday, March 22, 2019EXTENSION 4 FILED
Friday, March 22, 2019TEAS EXTENSION RECEIVED
Tuesday, September 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 21, 2018EXTENSION 3 GRANTED
Friday, September 21, 2018EXTENSION 3 FILED
Friday, September 21, 2018TEAS EXTENSION RECEIVED
Wednesday, March 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 26, 2018EXTENSION 2 GRANTED
Monday, March 26, 2018EXTENSION 2 FILED
Monday, March 26, 2018TEAS EXTENSION RECEIVED
Tuesday, September 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 23, 2017EXTENSION 1 GRANTED
Saturday, September 23, 2017EXTENSION 1 FILED
Saturday, September 23, 2017TEAS EXTENSION RECEIVED
Tuesday, March 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 31, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 31, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 11, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 21, 2016ASSIGNED TO EXAMINER
Wednesday, November 2, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 1, 2016NEW APPLICATION ENTERED IN TRAM